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Abstract 
BACKGROUND: Dengue virus infection is an infectious disease caused by the dengue virus and transmitted by 
the Aedes aegypti mosquito. Dengue virus (DEN-V) consists of 4 serotypes, namely DEN-1, DEN-2, DEN-3, and 
DEN-4. The most feared result of DHF is death. Death in children is caused by hypovolemic shock due to plasma 
leakage from intravascular to extravascular space due to endothelial dysfunction. 
AIM: This study aims to analyse difference in sVE-Cadherin levels in Dengue Hemorrhagic Fever (DHF) with and 
without shock. 
MATERIAL AND METHODS: The method of taking samples is consecutive sampling, namely the research 
subjects obtained based on the order of entry in the hospital with a comparative cross-sectional design. From the 
results of the calculation using the sample formula, the sample size for each group is set at 32 people. So that the 
total sample size used for both groups is 64 people. The serum sVE-Cadherin levels using the ELISA method. 
The statistical test used is the independent t-test. The value of p < 0.05 was said to be statistically significant.  
RESULTS: The result showed that there was no difference in mean sVE-Cadherin levels between DHF patients 
with shock and without shock (p > 0.05). 
CONCLUSION: This study concluded that there was no difference in mean of sVE-Cadherin level in DHF patients 
with shock and without shock. 
 
 
 
 
Introduction 
 
Dengue virus infection is an infectious 
disease caused by the dengue virus and is 
transmitted by the mosquito Aedes aegypti [1]. In 
dengue infection after the virus enters the body, the 
virus will infect Langerhans, dendrites, macrophages 
and B lymphocytes [2], [3], [4]. These infections 
produce various mediators that have an impact on 
endothelial cell function [5]. Langerhans, dendrites, 
macrophages and B lymphocytes that are infected will 
experience activation, securing mediators TNF-α, IL-8, 
IL-10, IL-15, IL-18, RANTES, MCP-Iα, MCP-Iβ, 
monokine, histamine and vascular endothelial growth 
factor (VEGF) [6], [7], [8]. 
Furthermore, MHC class II presents the 
dengue virus to T lymphocytes and T lymphocytes will 
stimulate macrophages to kill viruses that have been 
previously deposited. Infected B lymphocytes, after 
binding to T lymphocytes, will transform into plasma 
cells and then produce antibodies. Furthermore, 
antibodies will bind and neutralise circulating viruses, 
activate the complement system and cross-react with 
platelets, endothelial cells and hepatocytes (transient 
autoimmune) [9]. Antibodies that cannot neutralize the 
virus will bind the dengue virus and function as 
opsonin. The antibody-virus bond then binds to the Fc 
receptor on the surface of the macrophage to cause 
signals into the cell and activate macrophages [2]. 
Proinflammatory cytokines, VEGF, 
complement and antibodies released by the immune 
system including macrophages result in endothelial 
cells contracting actin filaments in the capillary 
endothelial cell cytoplasm. The contraction will pull in 
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the link protein between cells, JAMs and sVE-
Cadherin that enter the cells resulting in widening of 
the gap between endothelial cells resulting in plasma 
leakage. Severe and prolonged plasma leakage can 
cause hypovolemic shock and even death of the 
patient [10]. 
Dengue research using endothelial tissue 
culture in patients with dengue infection showed 
endocytosis of sVE-Cadherin in endothelial cells that 
were activated. Endocytosis decreases levels of sVE-
Cadherin, in endothelial cells which are directly 
proportional to the severity of plasma leakage. This 
shows that sVE-Cadherin plays an important role in 
maintaining the integrity of the link between 
endothelial cells and its level can be used as a 
parameter of plasma leakage [11].  
This study aims to analyse difference in sVE-
Cadherin levels in Dengue Hemorrhagic Fever (DHF) 
with and without shock. 
 
 
Material and Methods 
 
This study was an observational study with a 
comparative cross-sectional design. the sVE-Chaderin 
examination was carried out in the Biomedical 
Laboratory, Faculty of Medicine, Andalas University, 
Padang.  
 
Study Population 
The study population was patients with 
dengue virus infection (DHF and DSS) who were 
hospitalised at Dr M. Djamil Central General Hospital 
according to WHO 2011 criteria [12]. Subjects were 
part of the population that met the inclusion and 
exclusion criteria. The inclusion criteria were patients 
with dengue hemorrhagic fever who had received 
informed consent from parents to participate in the 
study with the age of 1-15 years. Exclusion criteria 
were patients suffering from other viral or bacterial 
infections based on clinical and laboratory 
examinations, receiving corticosteroid therapy, 
malnutrition and obesity. 
 
Examination of sVE-Cadherin Levels  
Blood samples ± 2-3 cc (which is checked in 
the critical phase) that were inserted into the serum 
tube were sent to the Biomedical Laboratory, Faculty 
of Medicine, Andalas University using media transport 
at 4°C. After that, prepare the microplate well as 
needed. Then, add 100 µL Diluent RD1-78 Assay into 
each well and add 50 µL of serum or standard or 
control into each well, cover with adhesive strip then 
incubate at room temperature and above the 
horizontal orbital microplate shaker set at 500 rpm + 
50 rpm. The aspirations of each well and washing, do 
3 times from a total of 4 washing times. Washing is 
done by entering 400 µL wash buffer. After that, add 
200 µL conjugate sVE-Cadherin to each well. Then 
cover with a new adhesive strip and incubate for 2 
hours. Perform the washing process again as in point 
5. After that, add 200 µL Substrate Solution to each 
well and incubate for 30 minutes at room temperature 
and on benchtop avoid light and then add 50 µL Stop 
Solution to each well to stop the reaction. The colour 
inside the well must change from yellowish blue. Read 
using a microplate reader with a wavelength of 450 
nm and a correction wavelength of 540 nm or 570 nm. 
Plot the standard curve and estimate the 
concentration of the sample against the curve. 
 
Statistical analysis 
The data obtained were analysed using 
computer systems in the form of tables and graphs. 
Bivariate analysis was performed to see the difference 
in mean sVE-Cadherin in DHF patients with shock 
and without shock. First, the data are analyzed using 
normality test to determine the normality of the data 
using the Shapiro Wilk test (n < 50), then followed by 
bivariate analysis, if the data is normally distributed 
then the analysis is done using the dependent test t-
test, but if it is known to be not normally distributed 
Mann-Whitney test was done with confident interval 
(CI) 95% and α = 0.05. The conclusion of the test 
results if the value of p ≤ 0.05 then H0 is rejected, 
meaning that there is a difference in the mean 
between the independent variables and the 
dependent variable. 
 
Research Ethics 
This study was already passed the ethics 
clearance and has been approved by the Ethics 
Committee of the Faculty of Medicine, Andalas 
University, Padang with registration number: 175 / 
KEP / FK / 2016. 
 
 
Results 
 
The difference in the results of sVE-Cadherin 
examination between dengue patients with shock 
compared to those without shock can be seen as 
follows. 
Table 1: Difference in the results of the examination of sVE-
Cadherin between DHF patients with shock and without shock 
 
Variable 
DHF  
p-value DSS (n = 62) mean ± SD DHF (n = 48) mean ± SD 
sVE-Cadherin 
(ng/ml) 
5.93 ± 4.87 5.86 ± 4.811 0.956 
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Table 1 showed that the average sVE-
Cadherin level in DHF patients with shock was 5.93 ± 
4.87 ng/ml, while in DHF patients without shock 5.86 ± 
4.811 ng/ml. From the results of statistical tests, there 
was no difference in mean sVE-Cadherin levels 
between DHF patients with shock and without shock 
(p > 0.05). 
 
The cut-off point for sVE-Cadherin levels 
 as a predictor of dengue patients with 
 shock 
The cut-off point of sVE-Chaderin levels as a 
predictor of dengue patients with shock is shown in 
Figure 1. 
 
Figure 1: Cut-off of sVE-Cadherin levels as predictors of DHF 
patients with shock with A); Blue (sensitivity); B) Red (specificity) 
 
Figure 1 shows that the optimal cut-off point 
on the intersection of sensitivity and specificity lines to 
determine the cut-off point of sVE-Cadherin levels as 
a predictor of DHF patients with shock is between 
point 50. Cut off points of sVE-Cadherin levels as 
predictors of DHF patients with shock can be 
explained as follows. Namely, subjects experiencing 
DSS, if the sVE-Cadherin level is ≥ 4.04 ng/ml and the 
subject has DHF if the sVE-Cadherin level is < 4.04 
ng/ml 
 
Figure 2: Accuracy of Cut-off point sVE-Cadherin levels as 
predictors of DHF patients with shock 
The cut-off point of this sVE-Cadherin 
sensitivity was 45.1%, and specificity was 45.8%. The 
accuracy of the cut-off point of sVE-Cadherin levels as 
a predictor of DHF patients with shock is shown in 
Figure 2. 
Figure 2 is known based on the receiver 
operating curve (ROC) analysis that the area under 
curve (AUC) value of 49.5% means that the cut-off 
point of sVE-Cadherin level of ≥ 4.04 ng/ml has poor 
accuracy in predicting DSS events. 
Table 2: Selection of candidate variables in predicting 
payments in DHF patients  
Variables p-value 
Long fever 0.274 
Mucosal bleeding 0.001† 
Abdominal pain 0.000† 
Sedentary vomiting 0.000† 
Hepatomegaly 0.000† 
Hematocrit 0.005† 
Platelets 0.000† 
sVE-Cadherin 0.956 
† qualify if p < 0.25. 
 
 
 
Discussion 
 
The difference in the results of sVE-
 Cadherin examination between DHF 
 patients with shock compared to without 
 shock  
Inter-cell links that maintain the paracellular 
path are tight junction and adhering junction. From the 
two links the main one is the adhering junction. The 
large gap between endothelial cells is maintained 
constant by various proton adhesions in the gap 
between endothelial cells. Among these adhesion 
proteins, sVE-Cadherin is the main adhesion protein. 
sVE-Cadherin is embedded in the actin tissue of the 
cortex of the endothelial cell and forms a homophilic 
bond with neighbouring sVE-Cadherin cells. The 
movement of water and various molecules that 
dissolve in the blood, mainly through the paracellular 
pathway, the integrity of the protein sVE-Chaderin 
adhesion is very necessary [13], [14].  
The Pober (2007) study found a statistically 
significant difference in the levels of sVE-Cadherin 
among DHF patients with and without shock (p < 
0.05). Leukocyte interaction with the endothelium 
during inflammation can change the composition of 
endothelial permeability. The stimulation of 
proinflammatory cytokines will result in the emergence 
of adhesion molecules on the surface of the 
leukocytes and endothelium. Activated endothelial 
cells due to cytokine stimulation will express adhesion 
molecules such as FIK-1 (E-selectin), ICAM-1, VCAM-
1, p-selectin and PECAM-1 on the endothelial surface 
[15], [16].  
These adhesion molecules make leukocytes 
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stick to the endothelial surface and secrete free 
radicals, proteases and cause local inflammation and 
endothelial cell damage. Also, leukocytes that bind to 
ICAM-1, through SRC and Rho GTPase, interfere with 
sVE-cadherin adherens junction. PECAM-1 which is 
the most important molecule binds to leukocyte cells 
in the inter-endothelial gap, attracts and causes 
leukocyte migration. Endothelial damage that 
interferes with VE-cadherin adherent junction and 
migrated leukocytes widens the gap between the 
endothelium, causing and aggravating plasma 
leakage [17], [18].  
The study of sVE-cadherin in dengue infection 
has so far only been in the in vitro research stage 
using endothelial tissue culture. This approach shows 
that the levels of sVE-cadherin decrease in leaky 
endothelial tissue (11). The release of 
proinflammatory cytokines, VEGF, antibodies and 
complement activation in the infection resulting in 
disruption of endothelial cell links, widening of the 
endothelial gap and leakage of plasma from the 
intravascular space to the extravascular space. 
Cardozo et al., (2017) investigating the effect 
of plasma leakage in patients with severe dengue 
infection getting vascular endothelial homeostasis 
plays an important role in plasma leakage, which is 
influenced by the immune response. Dengue virus 
affects endothelial cells to produce proinflammatory 
cytokines and chemokines such as IL-8, RANTES, 
MMP-2 and VEGF. Dengue infection also suppresses 
the production of TNF-α which mediates vascular 
hyperpermeability. PMBCs (peripheral mononuclear 
blood cells) also play a role in increasing endothelial 
cell permeability by decreasing the expression of sVe-
cadherin. It can be concluded that the decrease in 
sVE-Cadherin values in individuals with dengue 
infection indicates an increased risk of becoming more 
severe infections [19], [11].  
In vitro research by Yacoub et al., (2016) and 
Kanlaya et al., (2009) in the endothelial model found 
that the dengue virus can bind to EGL, reducing the 
expression of VE-cadherin and tight junction ZO-I 
proteins, causing an increase in plasma permeability 
[20], [21]. 
 
The difference of candidate variables in 
 predicting payments in DHF patients  
Fever, abdominal pain and vomiting are also 
symptoms that are often found in DHF and are a 
warning sign in dengue cases. Abdullah et al., (2018) 
found that there were significant differences between 
persistent vomiting, fluid accumulation and mucosal 
bleeding with the severity of dengue infection and had 
high sensitivity and specificity in predicting the 
occurrence of severe dengue infection [22]. Nagaram 
(2017) found 73 cases with complaints of abdominal 
pain and 115 cases with vomiting. In DHF patients, 
32.8% of cases of abdominal pain were obtained, and 
60.4% of cases of vomiting in patients with DSS had 
96% of cases reduced and 100% of cases of vomiting. 
Research conducted by researchers also found that 
there was a relationship between abdominal pain and 
vomiting with DHF in shock. Although dengue virus is 
a nonhepatotropic infection, liver injury often occurs, 
ranging from mild dysfunction to an increase in liver 
enzymes to those with severe yellow symptoms and 
even fulminant liver failure [23]. 
The Nagaram (2017) study obtained 100% 
hepatomegaly in the DSS case group and 77% in the 
DHF group [23]. Research by Zhang et al., (2014) 
found hepatomegaly in children with dengue infection 
had a 5 times greater risk of death compared to 
children infected with dengue without the discovery of 
hepatomegaly. From the above review compared to 
this study, there was a relationship between mucosal 
bleeding, abdominal pain, persistent vomiting and 
hepatomegaly with DHF with shock (p < 0.05) [24]. 
This study concluded that there was no 
difference in mean levels of sVE-Cadherin in DHF 
patients with shock and without shock. 
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